Fulcrum Therapeutics Cash Flow Statement (2019-2026) | FULC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-19.65M	-20.72M	-23.48M	-25.93M	-34.07M	-23.74M	-26.14M	-24.78M	-23.78M	-24.02M	-24.76M	-26.87M	55.41M	-21.70M	-16.57M	-17.66M	-17.30M	-19.59M	-20.33M	-18.89M
Depreciation and Depletion (Quarter)	0.70M	0.60M	0.62M	0.50M	0.70M	0.60M	0.60M	0.57M	0.60M	0.50M	0.54M	0.50M	0.40M	0.40M	0.40M	0.40M	0.30M	0.30M	0.40M	0.34M
Share-based Compensation (Quarter)	2.55M	2.66M	3.79M	3.85M	2.88M	3.35M	3.27M	4.25M	3.36M	3.74M	3.45M	3.92M	4.34M	3.82M	2.48M	3.17M	2.88M	3.36M	3.07M	3.86M
Gains from Sales and Divestitures (Quarter)	0.05M	0.04M	0.04M	0.01M		0.01M		0.01M	0.02M	0.02M	0.02M	0.01M	0.02M	0.02M	0.02M	0.01M	0.02M	0.02M	0.02M	0.02M
Gains from Investment Securities (Quarter)	0.21M	4.96M	0.50M	0.40M	2.20M	0.10M		0.20M		0.04M		0.80M	0.10M	2.86M	-0.81M		3.60M	0.06M	-0.20M	0.05M
Non-cash Items (Quarter)	3.95M	75.62M	1.48M	67.31M	0.00M	1.57M	1.89M		2.79M	4.87M	15.11M	3.37M	12.34M	1.30M	5.35M	0.15M	5.42M	5.91M	61.39M	6.44M
Cash from Operations (Quarter)	-17.82M	-22.57M	-21.86M	-22.11M	-27.37M	-27.88M	-19.70M	-24.12M	-20.79M	-22.91M	-23.16M	-25.28M	58.90M	-19.07M	-16.76M	-15.26M	-13.82M	-14.19M	-16.80M	-18.75M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.12M	-0.09M	-0.39M	-0.35M	-0.29M	-0.11M	0.60M	1.37M	1.71M	1.58M	1.33M	1.16M	1.13M	1.15M	0.94M	0.90M	1.08M	0.59M	0.38M	0.77M
Depreciation & Amortization (CF) (Quarter)	0.70M	0.60M	0.62M	0.50M	0.70M	0.60M	0.60M	0.57M	0.60M	0.50M	0.54M	0.50M	0.40M	0.40M	0.40M	0.40M	0.30M	0.30M	0.40M	0.34M
Change in Working Capital
Change in Receivables (Quarter)	0.12M	0.51M	-0.14M	0.34M	0.06M	2.09M	-4.99M	-0.13M	0.56M	-0.08M	-0.04M	-0.54M	2.33M	1.32M	-1.56M	-1.12M	-0.98M
Change in Account Payables (Quarter)	-0.30M	-0.82M	1.18M	0.51M	-0.04M	-2.55M	0.90M	0.09M	0.16M	-0.29M	-0.82M	1.10M	-0.29M	0.30M	-2.70M	0.34M	0.24M	0.95M	-1.10M	0.86M
Change in Accured Expenses (Quarter)	2.41M	2.35M	-0.80M	-2.40M	5.84M	-4.46M	1.56M	-2.20M	0.77M	-0.31M	0.91M	-3.92M	2.23M	1.30M	-0.64M	-3.34M	0.59M	1.49M	2.29M	-3.77M
Investing Activities
Capital Expenditures (Quarter)	0.79M	0.37M	-1.16M	0.25M	1.32M	0.28M	-1.82M	0.08M	-0.03M	-0.05M	0.51M	0.03M		0.02M	0.23M		0.07M	0.09M	0.16M	0.01M
Change in Intangibles (Quarter)
Cash from Investing Activities (Quarter)	-26.35M	-106.64M	-9.09M	19.66M	31.39M	-2.28M	-36.36M	-93.94M	19.88M	19.02M	18.35M	38.13M	-12.51M	4.35M	2.26M	-0.78M	13.93M	18.61M	-1.05M	-128.21M
Financing Activities
Other financing activities (Quarter)																				0.33M
Debt Issuance and Repayment
Long-Term Debt Repayments (Quarter)	0.01M	-0.00M	0.00M
Change in Capital Stock
Shares Issued (Quarter)	0.23M	2.38M	0.97M	0.05M	3.11M	0.09M	0.27M	0.35M	0.14M		0.29M	1.65M	0.38M	0.64M	0.08M		0.30M	0.06M	3.80M	0.02M
Misc.
Cash from Financing Activities (Quarter)	0.21M	137.90M	0.89M	0.35M	2.81M	80.95M	0.22M	117.69M	0.14M		0.29M	1.65M	0.38M	0.64M	0.08M		0.30M	0.06M	168.30M	-0.31M
Change in Cash (Quarter)	-43.97M	8.69M	-30.06M	-2.10M	6.84M	50.78M	-55.84M	-0.36M	-0.77M	-3.89M	-4.52M	14.49M	46.77M	-14.09M	-14.42M	-16.03M	0.41M	4.49M	150.46M	-147.27M
Free Cash Flow (Quarter)	-18.61M	-22.94M	-20.70M	-22.35M	-28.68M	-28.16M	-17.88M	-24.20M	-20.75M	-22.86M	-23.67M	-25.31M	58.90M	-19.09M	-16.99M	-15.26M	-13.88M	-14.28M	-16.96M	-18.76M
Net Cash Flow (Quarter)	-43.97M	8.69M	-30.06M	-2.10M	6.84M	50.78M	-55.84M	-0.36M	-0.77M	-3.89M	-4.52M	14.49M	46.77M	-14.09M	-14.42M	-16.03M	0.41M	4.49M	150.46M	-147.27M

Research Tools

Fulcrum Therapeutics Cash Flow Statement (2019-2026) | FULC

Create an account

Sign In

Reset Password